X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2025-02-10 | TKO | Tko Group Holdings, Inc. | Whitesell Patrick | 10% | P - Purchase | $174.48 | +390,471 | 4,404,467 | +10% | +$68,128,471 | |||||
M | 2025-02-10 | TKO | Tko Group Holdings, Inc. | Emanuel Ariel | CEO, 10% | P - Purchase | $174.48 | +390,471 | 4,470,646 | +10% | +$68,128,471 | |||||
M | 2025-02-10 | TKO | Tko Group Holdings, Inc. | Silver Lake West Holdco, L.P. | 10% | P - Purchase | $174.48 | +390,471 | 4,404,467 | +10% | +$68,128,471 | |||||
D | 2025-02-07 | OXY | Occidental Petroleum Corp /De/ | Berkshire Hathaway Inc | 10% | P - Purchase | $46.82 | +763,017 | 265,026,328 | 0% | +$35,724,074 | |||||
M | 2025-02-28 | OMI | Owens & Minor Inc/va/ | Coliseum Capital Management, LLC | 10% | P - Purchase | $9.47 | +2,893,412 | 20,094,297 | +17% | +$27,386,158 | |||||
M | 2025-03-05 | JANX | Janux Therapeutics, Inc. | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $30.75 | +824,041 | 11,189,693 | +8% | +$25,342,965 | |||||
D | 2025-03-05 | TNYA | Tenaya Therapeutics, Inc. | Column Group III Gp, LP | 10% | P - Purchase | $0.70 | +35,714,284 | 58,713,849 | +155% | +$24,999,999 | |||||
D | 2025-03-05 | TNYA | Tenaya Therapeutics, Inc. | Goeddel David V | Dir, 10% | P - Purchase | $0.70 | +35,714,284 | 58,713,849 | +155% | +$24,999,999 | |||||
2025-02-14 | ATAI | Atai Life Sciences N.V. | Apeiron Investment Group Ltd. | 10% | P - Purchase | $2.10 | +10,835,718 | 42,354,517 | +34% | +$22,755,008 | ||||||
D | 2025-02-10 | SION | Sionna Therapeutics, Inc. | Tpg Gp A, LLC | 10% | P - Purchase | $18.00 | +1,125,000 | 6,684,962 | +20% | +$20,250,000 | |||||
2025-02-19 | SLDB | Solid Biosciences Inc. | Perceptive Advisors LLC | Dir, 10% | P - Purchase | $4.03 | +5,000,000 | 11,906,646 | +72% | +$20,150,000 | ||||||
D | 2025-02-14 | AARD | Aardvark Therapeutics, Inc. | Decheng Capital Global Life Sciences Fund Iv, L.P. | 10% | P - Purchase | $16.00 | +1,250,000 | 3,917,299 | +47% | +$20,000,000 | |||||
M | 2025-03-07 | TRS | Trimas Corp | Sedaghat Shawn | Dir, 10% | P - Purchase | $24.00 | +803,746 | 5,071,641 | +19% | +$19,288,114 | |||||
2025-02-24 | AMKR | Amkor Technology, Inc. | Sujoda Investments, LP | Member of 10% owner group (2) | P - Purchase | $21.85 | +869,565 | 3,347,890 | +35% | +$18,999,995 | ||||||
2025-02-24 | AMKR | Amkor Technology, Inc. | Kim Susan Y | Member of 10% owner group (6), 10% | P - Purchase | $21.85 | +869,565 | 60,862,457 | +1% | +$18,999,995 | ||||||
2025-02-24 | AMKR | Amkor Technology, Inc. | Kim John T | Member of 10% owner group (5), 10% | P - Purchase | $21.85 | +869,565 | 94,390,027 | +1% | +$18,999,995 | ||||||
2025-02-24 | AMKR | Amkor Technology, Inc. | Sujoda Management, LLC | Member of 10% owner group (4) | P - Purchase | $21.85 | +869,565 | 3,347,890 | +35% | +$18,999,995 | ||||||
2025-02-24 | AMKR | Amkor Technology, Inc. | Kim David D | Member of 10% owner group (5) | P - Purchase | $21.85 | +869,565 | 6,055,149 | +17% | +$18,999,995 | ||||||
2025-02-18 | RCUS | Arcus Biosciences, Inc. | Gilead Sciences, Inc. | 10% | P - Purchase | $11.00 | +1,363,636 | 31,424,760 | +5% | +$14,999,996 | ||||||
M | 2024-06-21 | TPIC | Tpi Composites, Inc | Dere Construction Taahhut A.S. | 10% | P - Purchase | $1.83 | +7,026,105 | 100 | -100% | +$12,891,120 | |||||
M | 2025-02-28 | AUPH | Aurinia Pharmaceuticals Inc. | Tang Kevin | Dir | P - Purchase | $7.95 | +1,600,000 | 10,029,500 | +19% | +$12,713,126 | |||||
M | 2025-02-27 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $16.99 | +663,761 | 23,932,296 | +3% | +$11,275,555 | |||||
2025-02-14 | JBHT | Hunt J B Transport Services Inc | Robo James L | Dir | P - Purchase | $168.21 | +59,447 | 113,735 | +110% | +$9,999,474 | ||||||
M | 2025-02-12 | CMPO | Composecure, Inc. | Resolute Compo Holdings LLC | Dir, 10% | P - Purchase | $15.44 | +646,893 | 49,937,302 | +1% | +$9,986,150 | |||||
M | 2025-02-12 | CMPO | Composecure, Inc. | Cote John D. | Dir, 10% | P - Purchase | $15.44 | +646,893 | 51,437,302 | +1% | +$9,986,150 | |||||
M | 2025-02-12 | CMPO | Composecure, Inc. | Knott Thomas R. | Dir, 10% | P - Purchase | $15.44 | +646,893 | 49,937,302 | +1% | +$9,986,150 | |||||
M | 2025-03-03 | PR | Permian Resources Corp | Quinn William J | Dir | P - Purchase | $12.83 | +750,000 | 1,062,429 | +240% | +$9,622,450 | |||||
2024-11-08 | VLY | Valley National Bancorp | Bank Leumi Le Israel Bm | 10% | P - Purchase | $9.35 | +1,000,000 | 72,861,862 | +1% | +$9,350,000 | ||||||
M | 2025-02-28 | CVI | Cvr Energy Inc | Icahn Carl C | 10% | P - Purchase | $17.89 | +377,260 | 67,947,853 | +1% | +$6,749,837 | |||||
M | 2025-02-12 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $15.25 | +411,430 | 22,604,774 | +2% | +$6,274,767 | |||||
M | 2025-02-20 | SEPN | Septerna, Inc. | Third Rock Ventures Vi, L.P. | 10% | P - Purchase | $5.93 | +1,040,342 | 10,408,389 | +11% | +$6,167,378 | |||||
M | 2025-02-13 | MRP | Millrose Properties, Inc. | Richman Darren | See Remarks | P - Purchase | $22.65 | +265,000 | 265,000 | New | +$6,001,505 | |||||
M | 2025-02-25 | PBF | Pbf Energy Inc. | Control Empresarial De Capitales S.A. De C.V. | Add'l Rep. Persons-see Ex.99-1, 10% | P - Purchase | $22.23 | +263,000 | 29,974,998 | +1% | +$5,846,806 | |||||
M | 2025-02-19 | FLWS | 1 800 Flowers Com Inc | Fund 1 Investments, LLC | 10% | P - Purchase | $8.01 | +684,000 | 7,084,969 | +11% | +$5,479,082 | |||||
2025-02-28 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.07 | +4,820,959 | 19,490,326 | +33% | +$5,134,321 | ||||||
2025-03-03 | MRNA | Moderna, Inc. | Bancel Stephane | CEO | P - Purchase | $31.22 | +160,314 | 21,269,463 | +1% | +$5,004,318 | ||||||
2025-02-20 | SSII | Ss Innovations International, Inc. | Moll Frederic H | Dir, 10% | P - Purchase | $1.37 | +3,645,224 | 10,060,813 | +57% | +$5,001,247 | ||||||
D | 2024-06-25 | RZLT | Rezolute, Inc. | Kim Young-Jin | Dir | P - Purchase | $4.00 | +1,250,000 | 7,333,567 | +21% | +$5,000,000 | |||||
2025-02-13 | PBF | Pbf Energy Inc. | Control Empresarial De Capitales S.A. De C.V. | Add'l Rep. Persons-see Ex.99-1, 10% | P - Purchase | $23.80 | +200,000 | 29,705,998 | +1% | +$4,760,699 | ||||||
2025-03-10 | MEGI | Nyli Cbre Global Infrastructure Megatrends Term Fund | Saba Capital Management, L.P. | 10% | P - Purchase | $12.48 | +379,538 | 6,169,266 | +7% | +$4,736,634 | ||||||
2025-03-07 | BLND | Blend Labs, Inc. | Haveli Investments, L.P. | Dir, 10% | P - Purchase | $3.05 | +1,416,037 | 2,190,925 | +183% | +$4,320,754 | ||||||
D | 2025-02-19 | SLDB | Solid Biosciences Inc. | Bain Capital Life Sciences Investors, LLC | 10% | P - Purchase | $4.03 | +1,000,000 | 5,034,582 | +25% | +$4,030,000 | |||||
2025-02-20 | CMPO | Composecure, Inc. | Knott Thomas R. | Dir, 10% | P - Purchase | $16.57 | +233,070 | 50,170,372 | 0% | +$3,861,970 | ||||||
2025-02-20 | CMPO | Composecure, Inc. | Resolute Compo Holdings LLC | Dir, 10% | P - Purchase | $16.57 | +233,070 | 50,170,372 | 0% | +$3,861,970 | ||||||
2025-02-20 | CMPO | Composecure, Inc. | Cote John D. | Dir, 10% | P - Purchase | $16.57 | +233,070 | 51,670,372 | 0% | +$3,861,970 | ||||||
D | 2025-03-03 | FERA | Fifth Era Acquisition Corp I | Fifth Era Acquisition Sponsor I LLC | 10% | P - Purchase | $10.00 | +380,000 | 380,000 | New | +$3,800,000 | |||||
M | 2025-03-05 | CVI | Cvr Energy Inc | Icahn Carl C | 10% | P - Purchase | $17.98 | +203,219 | 68,151,072 | 0% | +$3,654,697 | |||||
M | 2025-03-03 | TKO | Tko Group Holdings, Inc. | Kraft Jonathan | Dir | P - Purchase | $150.13 | +23,500 | 36,532 | +180% | +$3,528,112 | |||||
M | 2025-02-19 | TBRG | Trubridge, Inc. | Pinetree Capital Ltd. | 10% | P - Purchase | $28.17 | +124,858 | 3,212,332 | +4% | +$3,517,144 | |||||
M | 2025-02-24 | TBRG | Trubridge, Inc. | L6 Holdings Inc. | 10% | P - Purchase | $28.14 | +117,609 | 4,337,804 | +3% | +$3,309,408 | |||||
2025-03-03 | PBF | Pbf Energy Inc. | Control Empresarial De Capitales S.A. De C.V. | Add'l Rep. Persons-see Ex.99-1, 10% | P - Purchase | $20.21 | +155,000 | 30,249,998 | +1% | +$3,131,775 | ||||||
M | 2025-02-13 | TBRG | Trubridge, Inc. | Pinetree Capital Ltd. | 10% | P - Purchase | $27.74 | +110,176 | 3,048,157 | +4% | +$3,056,802 | |||||
2025-02-24 | MSCI | Msci Inc. | Fernandez Henry A | COB, CEO | P - Purchase | $574.51 | +5,300 | 2,153,237 | 0% | +$3,044,902 | ||||||
2025-03-05 | PR | Permian Resources Corp | Quinn William J | Dir | P - Purchase | $12.10 | +250,000 | 1,312,429 | +24% | +$3,024,525 | ||||||
D | 2025-02-14 | AARD | Aardvark Therapeutics, Inc. | Cormorant Asset Management, LP | Former 10% Owner | P - Purchase | $16.00 | +187,500 | 987,689 | +23% | +$3,000,000 | |||||
A | 2024-04-22 | BHVN | Biohaven Ltd. | Childs John W | Dir | P - Purchase | $41.00 | +73,170 | 2,254,841 | +3% | +$2,999,970 | |||||
2025-02-27 | AKAM | Akamai Technologies Inc | Leighton F Thomson | CEO | P - Purchase | $79.58 | +37,670 | 2,588,321 | +1% | +$2,997,933 | ||||||
M | 2025-02-13 | APPF | Appfolio Inc | Wolf Alexander | Dir | P - Purchase | $215.07 | +13,500 | 221,084 | +7% | +$2,903,482 | |||||
2025-03-03 | THM | International Tower Hill Mines Ltd | Paulson & Co. Inc. | 10% | P - Purchase | $0.48 | +6,040,408 | 70,239,388 | +9% | +$2,900,000 | ||||||
M | 2025-02-27 | PBF | Pbf Energy Inc. | Control Empresarial De Capitales S.A. De C.V. | Add'l Rep. Persons-see Ex.99-1, 10% | P - Purchase | $21.17 | +120,000 | 30,094,998 | 0% | +$2,540,004 | |||||
M | 2025-03-07 | NCMI | National Cinemedia, Inc. | Blantyre Capital Ltd | 10% | P - Purchase | $5.16 | +480,290 | 16,790,089 | +3% | +$2,480,627 | |||||
2025-02-12 | SCISX | Ma Specialty Credit Income Fund | Ma Eagle II Holdings Fund | 10% | P - Purchase | $24.99 | +97,825 | 2,826,568 | +4% | +$2,444,642 | ||||||
2025-02-26 | ACDC | Profrac Holding Corp. | Wilks Farris | 10% | P - Purchase | $6.93 | +338,756 | 60,714,354 | +1% | +$2,347,579 | ||||||
2025-03-10 | VG | Venture Global, Inc. | Sabel Michael | See Remarks, 10% | P - Purchase | $9.37 | +250,000 | 250,000 | New | +$2,342,500 | ||||||
2025-03-10 | VG | Venture Global, Inc. | Pender Robert B | See Remarks, 10% | P - Purchase | $9.37 | +250,000 | 250,000 | New | +$2,342,500 | ||||||
DM | 2025-02-27 | FLWS | 1 800 Flowers Com Inc | Fund 1 Investments, LLC | 10% | P - Purchase | $6.89 | +335,500 | 7,642,969 | +5% | +$2,310,868 | |||||
M | 2025-02-27 | TTSH | Tile Shop Holdings, Inc. | Fund 1 Investments, LLC | 10% | P - Purchase | $7.44 | +301,500 | 12,454,767 | +2% | +$2,244,166 | |||||
2025-02-07 | OCX | Oncocyte Corp | Smith Patrick W | 10% | P - Purchase | $2.05 | +1,077,600 | 3,258,485 | +49% | +$2,209,080 | ||||||
2025-02-12 | AMTM | Amentum Holdings, Inc. | Demetriou Steven J. | Exec Chair | P - Purchase | $20.81 | +100,000 | 644,443 | +18% | +$2,080,700 | ||||||
2025-02-18 | WYNN | Wynn Resorts Ltd | Satre Philip G | Dir | P - Purchase | $92.18 | +22,200 | 55,484 | +67% | +$2,046,396 | ||||||
2025-02-28 | GO | Grocery Outlet Holding Corp. | Ragatz Erik D. | Dir | P - Purchase | $12.25 | +165,000 | 822,274 | +25% | +$2,021,250 | ||||||
M | 2025-02-14 | MBX | Mbx Biosciences, Inc. | Gordon Carl L | Dir, 10% | P - Purchase | $10.60 | +190,672 | 747,887 | +34% | +$2,020,756 | |||||
M | 2025-02-14 | MBX | Mbx Biosciences, Inc. | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $10.60 | +190,672 | 747,887 | +34% | +$2,020,756 | |||||
2025-03-04 | IFF | International Flavors & Fragrances Inc | Fyrwald J Erik | CEO | P - Purchase | $80.24 | +25,000 | 40,590 | +160% | +$2,005,878 | ||||||
2025-02-26 | ACDC | Profrac Holding Corp. | Wilks Matthew | Exec COB | P - Purchase | $6.93 | +288,756 | 1,806,432 | +19% | +$2,001,079 | ||||||
2025-02-18 | CVS | Cvs Health Corp | Mahoney Michael F | Dir | P - Purchase | $66.70 | +30,000 | 45,767 | +190% | +$2,001,000 | ||||||
2025-03-11 | VG | Venture Global, Inc. | Sabel Michael | See Remarks, 10% | P - Purchase | $9.86 | +200,385 | 450,385 | +80% | +$1,975,796 | ||||||
2025-03-11 | VG | Venture Global, Inc. | Pender Robert B | See Remarks, 10% | P - Purchase | $9.86 | +200,385 | 450,385 | +80% | +$1,975,796 | ||||||
2025-03-04 | BEN | Franklin Resources Inc | Johnson Charles B | 10% | P - Purchase | $19.57 | +100,000 | 93,459,244 | 0% | +$1,957,000 | ||||||
2025-03-04 | FMC | Fmc Corp | Brondeau Pierre R | COB, CEO | P - Purchase | $35.90 | +54,000 | 298,439 | +22% | +$1,938,449 | ||||||
2025-03-05 | PBF | Pbf Energy Inc. | Control Empresarial De Capitales S.A. De C.V. | Add'l Rep. Persons-see Ex.99-1, 10% | P - Purchase | $19.13 | +100,000 | 30,349,998 | 0% | +$1,912,640 | ||||||
2025-02-18 | SLDB | Solid Biosciences Inc. | Adage Capital Management, L.P. | 10% | P - Purchase | $7.56 | +252,545 | 4,248,084 | +6% | +$1,909,240 | ||||||
2025-03-06 | BLND | Blend Labs, Inc. | Haveli Investments, L.P. | Dir, 10% | P - Purchase | $3.05 | +587,149 | 774,888 | +313% | +$1,790,863 | ||||||
2025-03-11 | NFE | New Fortress Energy Inc. | Edens Wesley R | CEO, 10% | P - Purchase | $8.77 | +200,000 | 53,534,666 | 0% | +$1,754,000 | ||||||
2025-02-14 | SSII | Ss Innovations International, Inc. | Adams Timothy P. | Dir | P - Purchase | $1.37 | +1,250,000 | 5,031,902 | +33% | +$1,715,000 | ||||||
M | 2025-02-24 | FLWS | 1 800 Flowers Com Inc | Fund 1 Investments, LLC | 10% | P - Purchase | $7.48 | +222,500 | 7,307,469 | +3% | +$1,663,570 | |||||
2025-03-05 | FLGT | Fulgent Genetics, Inc. | Kim Paul | CFO, Treasurer | P - Purchase | $15.96 | +100,000 | 348,282 | +40% | +$1,596,470 | ||||||
2025-03-06 | WD | Walker & Dunlop, Inc. | Walker William M | COB, CEO | P - Purchase | $86.21 | +17,500 | 963,283 | +2% | +$1,508,671 | ||||||
M | 2025-02-12 | KALV | Kalvista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners Iii, L.P. | 10% | P - Purchase | $9.27 | +161,700 | 5,278,985 | +3% | +$1,498,661 | |||||
2025-02-28 | LINE | Lineage, Inc. | Forste Adam Matthew Schwartz | CO-Exec COB, 10% | P - Purchase | $60.50 | +24,317 | 157,430,737 | 0% | +$1,471,144 | ||||||
M | 2025-02-26 | ADVM | Adverum Biotechnologies, Inc. | Leonard Braden Michael | 10% | P - Purchase | $4.27 | +336,756 | 2,709,620 | +14% | +$1,439,087 | |||||
2025-03-10 | ECAT | Blackrock Esg Capital Allocation Term Trust | Blackrock, Inc. | See Remarks | P - Purchase | $16.38 | +86,000 | 329,800 | +35% | +$1,408,680 | ||||||
M | 2025-02-10 | ORKA | Oruka Therapeutics, Inc. | Venrock Healthcare Capital Partners Iii, L.P. | 10% | P - Purchase | $11.45 | +122,882 | 4,148,428 | +3% | +$1,407,368 | |||||
2025-03-05 | ECPG | Encore Capital Group Inc | Gupta Ashwini | Dir | P - Purchase | $35.10 | +40,000 | 96,909 | +70% | +$1,404,000 | ||||||
2025-03-11 | ECAT | Blackrock Esg Capital Allocation Term Trust | Blackrock, Inc. | See Remarks | P - Purchase | $16.24 | +86,000 | 415,800 | +26% | +$1,396,640 | ||||||
AM | 2024-08-27 | BILL | Bill Holdings, Inc. | Jacobs Brian | Dir | P - Purchase | $53.54 | +25,000 | 219,965 | +13% | +$1,338,397 | |||||
A | 2025-03-05 | ECAT | Blackrock Esg Capital Allocation Term Trust | Blackrock, Inc. | See Remarks | P - Purchase | $16.64 | +79,600 | 79,600 | New | +$1,324,544 | |||||
2025-03-05 | ECAT | Blackrock Esg Capital Allocation Term Trust | Blackrock, Inc. | See Remarks | P - Purchase | $16.64 | +79,600 | 84,600 | >999% | +$1,324,544 | ||||||
2025-03-06 | ECAT | Blackrock Esg Capital Allocation Term Trust | Blackrock, Inc. | See Remarks | P - Purchase | $16.62 | +79,600 | 164,200 | +94% | +$1,322,952 | ||||||
2025-03-07 | ECAT | Blackrock Esg Capital Allocation Term Trust | Blackrock, Inc. | See Remarks | P - Purchase | $16.50 | +79,600 | 243,800 | +48% | +$1,313,400 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |